Brian Baranick Exact Sciences Corp (EXAS) insider trading activity

Brian Baranick is EVP, GM, Precision Oncology of EXACT SCIENCES CORP. Currently has a direct ownership of 22,593 shares of EXAS, which is worth approximately $986,410. The most recent transaction as insider was on Feb 28, 2025, when has been sold 4,913 shares (Common Stock) at a price of $47.82 per share, resulting in proceeds of $234,939. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.6K

77.09% 3M change

60.29% 12M change

Total Value Held $986,410

Brian Baranick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2025	SELL Payment of exercise price or tax liability	$234,939 $47.82 p/Share	4,913 Reduced 17.86%	22,593 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	9,673 Added 27.81%	25,106 Common Stock
Feb 25 2025	SELL Payment of exercise price or tax liability	$102,970 $51.28 p/Share	2,008 Reduced 10.12%	17,833 Common Stock
Feb 25 2025	BUY Exercise of conversion of derivative security	-	3,954 Added 16.62%	19,841 Common Stock
Feb 20 2025	SELL Payment of exercise price or tax liability	$123,019 $50.48 p/Share	2,437 Reduced 13.3%	15,887 Common Stock
Feb 20 2025	BUY Grant, award, or other acquisition	-	4,805 Added 20.77%	18,324 Common Stock
Feb 19 2025	SELL Payment of exercise price or tax liability	$48,041 $49.63 p/Share	968 Reduced 6.68%	13,519 Common Stock
Feb 19 2025	BUY Exercise of conversion of derivative security	-	1,729 Added 10.66%	14,487 Common Stock
Oct 08 2024	SELL Open market or private sale	$65,030 $70.0 p/Share	929 Reduced 6.79%	12,758 Common Stock
Sep 18 2024	SELL Open market or private sale	$65,030 $70.0 p/Share	929 Reduced 6.36%	13,687 Common Stock
Aug 05 2024	SELL Payment of exercise price or tax liability	$76,683 $55.77 p/Share	1,375 Reduced 8.6%	14,616 Common Stock
Aug 05 2024	BUY Exercise of conversion of derivative security	-	2,712 Added 14.5%	15,991 Common Stock
May 01 2024	SELL Open market or private sale	$6,616 $60.15 p/Share	110 Reduced 0.82%	13,279 Common Stock
Apr 30 2024	BUY Grant, award, or other acquisition	-	218 Added 1.6%	13,389 Common Stock
Apr 02 2024	SELL Open market or private sale	$73,393 $79.43 p/Share	924 Reduced 6.56%	13,171 Common Stock
Mar 01 2024	SELL Open market or private sale	$137,800 $59.32 p/Share	2,323 Reduced 14.15%	14,095 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	-	4,724 Added 22.34%	16,418 Common Stock
Feb 27 2024	SELL Open market or private sale	$115,316 $56.89 p/Share	2,027 Reduced 14.77%	11,694 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	3,954 Added 22.37%	13,721 Common Stock
Feb 22 2024	SELL Open market or private sale	$65,339 $59.78 p/Share	1,093 Reduced 10.06%	9,767 Common Stock
Feb 21 2024	SELL Open market or private sale	$55,042 $61.5 p/Share	895 Reduced 9.21%	8,826 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	2,034 Added 15.77%	10,860 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	1,729 Added 15.1%	9,721 Common Stock
Jan 02 2024	SELL Open market or private sale	$64,606 $73.5 p/Share	879 Reduced 9.91%	7,992 Common Stock
Aug 07 2023	SELL Open market or private sale	$114,804 $85.04 p/Share	1,350 Reduced 13.21%	8,871 Common Stock

Brian Baranick

EVP, GM, Precision Oncology

Madison, WI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Value

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS

Account